Dental considerations of patients taking appetite suppressants.
Wynn
R L
RL
Department of Oral-Craniofacial Biological Sciences, Dental School, University of Maryland at Baltimore, USA.
D000328:Adult; D001067:Appetite Depressants / Q000009:adverse effects* / Q000494:pharmacology; D001589:Benzphetamine / Q000009:adverse effects / Q000494:pharmacology; D017742:Dental Care for Chronically Ill; D003731:Dental Caries / Q000209:etiology; D004053:Diethylpropion / Q000009:adverse effects / Q000494:pharmacology; D004347:Drug Interactions; D005260:Female; D005277:Fenfluramine / Q000009:adverse effects / Q000494:pharmacology; D006801:Humans; D008297:Male; D008454:Mazindol / Q000009:adverse effects / Q000494:pharmacology; D009025:Morpholines / Q000009:adverse effects / Q000494:pharmacology; D009765:Obesity / Q000188:drug therapy; D010510:Periodontal Diseases / Q000209:etiology; D010645:Phentermine / Q000009:adverse effects / Q000494:pharmacology; D010665:Phenylpropanolamine / Q000009:adverse effects / Q000494:pharmacology; D011247:Pregnancy; D014987:Xerostomia / Q000209:etiology*
D001067:Appetite Depressants; D009025:Morpholines; D001589:Benzphetamine; D005277:Fenfluramine; D010665:Phenylpropanolamine; C100294:phendimetrazine; D010645:Phentermine; D008454:Mazindol; D004053:Diethylpropion